Amgen Inc. earnings rise 20 per cent while Eli Lilly and Co. swings to profit

SAN FRANCISCO (AP) - Amgen Inc., the world's largest biotechnology company by sales, said Thursday its fourth-quarter earnings rose 20 per cent, driven by sales of its rheumatoid arthritis and anemia drugs. Meanwhile, the Indianapolis drugmaker Eli Lilly and Co....More